Isoniazid-Resveratrol Cocrystal: A Novel Alternative for Topical Treatment of Cutaneous Tuberculosis

doi 10.1021/acs.cgd.9b00313.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Acetylation of Isoniazid - A Novel Mechanism of Isoniazid Resistance in Mycobacterium Tuberculosis

2020English

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

InPharma
1988English

Isoniazid in Treatment of Bone and Joint Tuberculosis

BMJ
1954English

Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2009English

Effect of Isoniazid Resistance on the Tuberculosis Treatment Outcome

Archivos de Bronconeumologia
PulmonaryRespiratory Medicine
2018English

Tuberculin in Treatment of Cutaneous Tuberculosis

Journal of Allergy
1936English

Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Topical Treatment for Cutaneous Leishmaniasis – Dermato-Pharmacokinetic Led Optimisation of Benzoxaboroles

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy